Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Synthesis and Biological Activity of Reversed Pyrimidine Nucleosides (CROSBI ID 218367)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Župančić, Nataša ; Ban, Željka ; Matić, Josipa ; Saftić, Dijana ; Glavaš-Obrovac, Ljubica ; Žinić, Biserka Synthesis and Biological Activity of Reversed Pyrimidine Nucleosides // Croatica chemica acta, 88 (2015), 1; 43-52. doi: 10.5562/cca2531

Podaci o odgovornosti

Župančić, Nataša ; Ban, Željka ; Matić, Josipa ; Saftić, Dijana ; Glavaš-Obrovac, Ljubica ; Žinić, Biserka

engleski

Synthesis and Biological Activity of Reversed Pyrimidine Nucleosides

An efficient approach to reversed nucleosides which enables their synthesis in gram quantities is described. N-1′-Pyrimidine reversed nucleosides were prepared by treating of the sodium salt of pyrimidine bases with protected 5-tosyl ribose. Additionally, N-1′, N-3′-disubstituted reversed nucleosides were isolated in the condensation reactions with the 5-halogen pyrimidines. Using the Sonogashira coupling of 5′-iodouracil reversed nucleoside with ethynyltrimethyl silane gave 5′-ethynyl derivative which was further transformed into 5′-acetyl reversed nucleoside. Biological activity of deprotected reversed nucleosides was validated on the panel of six human carcinoma cell lines (HeLa, MIAPaCa2, Hep2, NCI-H358, CaCo-2, and HT-29). 5′-Iodouracil derivative displayed moderate growth inhibition activity against human colon carcinoma (CaCo-2) cells.

uracil ; 5-halogenuracil ; D-ribose ; reversed nucleosides ; antitumor activity

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

88 (1)

2015.

43-52

objavljeno

0011-1643

1334-417X

10.5562/cca2531

Povezanost rada

Kemija

Poveznice